Diabetic neuropathy

被引：0
作者：
Lechleitner, M
Francesconi, M
Abrahamian, H
机构：
[1] Univ Klin Innere Med, A-6020 Innsbruck, Austria
[2] SKA RZ Alland Pensionsversicherungsanstalt, Alland, Austria
[3] Krankenhaus Stadt Wien Lainz, Med Abt 3, Vienna, Austria
来源：
ACTA MEDICA AUSTRIACA | 2004年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
These are the guidelines for diagnosis and treatment of diabetic neuropathy. This diabetic late complication comprises a number of mono- and polyneuropathies, plexopathies, radiculopathies and autonomic neuropathy. The position statement summarizes characteristic clinical symptoms and techniques for diagnostic assessment of diabetic neuropathy. Recommendations for the therapeutic management of diabetic neuropathy, especially for the control of pain in sensorimotoric neuropathy, are provided.
引用
收藏
页码：171 / 172
页数：2
相关论文
共 7 条
  • [1] The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid -: The SYDNEY trial
    Ametov, AS
    Barinov, A
    Dyck, PJ
    Hermann, R
    Kozlova, N
    Litchy, WJ
    Low, PA
    Nehrdich, D
    Novosadova, M
    O'Brien, PC
    Reljanovic, M
    Samigullin, R
    Schuette, K
    Strokov, I
    Tritschler, H
    Wessel, K
    Yakhno, N
    Ziegler, D
    [J]. DIABETES CARE, 2003, 26 (03) : 770 - 776
  • [2] Diabetic somatic neuropathies
    Boulton, AJM
    Malik, RA
    Arezzo, JC
    Sosenko, JM
    [J]. DIABETES CARE, 2004, 27 (06) : 1458 - 1486
  • [3] THE PREVALENCE BY STAGED SEVERITY OF VARIOUS TYPES OF DIABETIC NEUROPATHY, RETINOPATHY, AND NEPHROPATHY IN A POPULATION-BASED COHORT - THE ROCHESTER DIABETIC NEUROPATHY STUDY
    DYCK, PJ
    KRATZ, KM
    KARNES, JL
    LITCHY, WJ
    KLEIN, R
    PACH, JM
    WILSON, DM
    OBRIEN, PC
    MELTON, LJ
    [J]. NEUROLOGY, 1993, 43 (04) : 817 - 824
  • [4] A PRACTICAL 2-STEP QUANTITATIVE CLINICAL AND ELECTROPHYSIOLOGICAL ASSESSMENT FOR THE DIAGNOSIS AND STAGING OF DIABETIC NEUROPATHY
    FELDMAN, EL
    STEVENS, MJ
    THOMAS, PK
    BROWN, MB
    CANAL, N
    GREENE, DA
    [J]. DIABETES CARE, 1994, 17 (11) : 1281 - 1289
  • [5] Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (α-lipoic acid):: A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II)
    Reljanovic, M
    Reichel, G
    Rett, K
    Lobisch, M
    Schuette, K
    Möller, W
    Tritschler, HJ
    Mehnert, H
    [J]. FREE RADICAL RESEARCH, 1999, 31 (03) : 171 - 179
  • [6] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853
  • [7] Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid -: A 7-month multicenter randomized controlled trial (ALADIN III Study)
    Ziegler, D
    Hanefeld, M
    Rahnau, KJ
    Hasche, H
    Lobisch, M
    Schütte, K
    Kerum, G
    Malessa, R
    [J]. DIABETES CARE, 1999, 22 (08) : 1296 - 1301
1